Skip to main content

Table 2 Anthropometric and clinical characteristics in migraine patients with and without cutaneous allodynia

From: Excess abdominal fat is associated with cutaneous allodynia in individuals with migraine: a prospective cohort study

VariablesMigraineurs with CA (n = 43)Migraineurs without CA (n = 37)p-value a
Age (years)41 ± 1137 ± 90.05
Female (%)86.5%75.7%0.24
Height (m)1.64 ± 0.091.65 ± 0.080.52
Weight (kg)64.7 ± 11.264.1 ± 12.40.79
BMI (kg/m2)24.1 ± 3.923.4 ± 3.10.42
Body composition – ViScan abdominal fat35.7 ± 8.732.9 ± 7.50.04
Body fat percentage32.6 ± 9.431.1 ± 7.780.07
HIT-662.68 ± 7.1958.47 ± 9.030.03
MIDAS54.83 ± 57.8329.03 ± 40.090.05
Migraine evolution (years)9.9 ± 8.69.7 ± 10.30.03
Frequency (attacks per month)9.49 ± 8.705.25 ± 5.170.23
 1–9 days per month23 (53.5%)28 (75.0%) 
 10–14 days per month1 (2.3%)1 (2.8%)0.31 b
 >  15 days per month19 (44.2%)8 (22.2%) 
Analgesic consumption (last month)11.32 ± 8.017.36 ± 7.390.03
Triptan consumption (last month)4.47 ± 6.693.05 ± 6.510.464
Medication overuse21 (48.8%)10 (27.0%)0.726 b
Use of migraine prophylaxis25 (59.5%)12 (32.4%)0.02 b
Depression (%)16.2%10.8%0.49 b
Anxiety disorders (%)37.2%37.5%0.95 b
Sleep disorders (%)69.8%43.2%0.02 b
  1. Anxiety and mood disorders as well as sleep disorders were self-reported
  2. BMI body mass index, CA cutaneous allodynia, HIT-6 6-item Headache Impact Test, MIDAS Migraine Disability Assessment
  3. a Two-tailed independent samples Student’s t/Mann–Whitney U tests
  4. b Chi-squared test
\